| 摘要 |
Methods and compositions are disclosed utilizing the optically pure (+)-isomer of bupropion, which is a potent drug for treating depression, Parkinson's disease, obesity, weight gain, bipolar, attention-deficit or conduct disorders, phychosexual dysfunction, bulima, eating disorders or specific food craving. The composition can be administered intravenously, transdermally (patch) or orally, possibly in a sustained release form.
|
